PoliticalRepoPoliticalRepo

United States · Bill · S

S. 3179 (102nd)

Agency for Health Care Policy and Research Reauthorization Act of 1992

openUnited States· United States Congress· EN

Introduced

12 August 1992

Last action

Status

Placed on Senate Legislative Calendar under General Orders. Calendar No. 743.

Sponsors

Subjects

Discovery layer

Source updated

21 April 2025

Summary

Agency for Health Care Policy and Research Reauthorization Act of 1992 - Amends the Public Health Service Act to add prevention of diseases and other health conditions to the purposes of the Agency for Health Care Policy and Research. Authorizes training grants in the field of health services research. Mandates: (1) the gathering, organizing, summarizing, and conveyance of technology assessment information to provide a single public source regarding assessment of health care technologies; (2) an annual report on technology assessments; and (3) conducting assessments of existing and new technologies, in part through an evaluation of health services provided through publicly and privately funded sources. Replaces provisions establishing at the National Library of Medicine (NLM) an information center on health care technologies and health care technology assessment with provisions mandating establishment and publication of a methodology for setting assessment priorities. Requires: (1) implementation of the methodology to produce, at least annually, a ranked list of assesements to be conducted or supported; and (2) annually conducting at least five of the high priority assessments. Requires the Office of Health Technology Assessment to publish a description of the process used to conduct its assessments. Establishes: (1) a program of grants, contracts, or cooperative agreements for public-private partnerships for conducting health care technology assessments of activities in the private sector; and (2) a task force to support interagency collaboration on health technology assessment, including the development of new and emerging technologies, the conduct of clinical trials, and consensus development. Requires, with regard to certain Agency guidelines, standards, performance measures, and review criteria: (1) inclusion of information on the risks, benefits, and costs of all alternative strategies; and (2) coverage, by a specified date, of at least three clinical treatments or conditions that account for a significant portion of national health expenditures, have significant variation in treatment, and are identified by a specified Advisory Council as likely to involve inappropriate use of health care resources. Establishes, as part of the single public health care technology assessment source established by this Act, a Resource Center for Clinical Practice Guidelines. Requires the NLM to establish a system to identify and collect practice guidelines and to provide information on guidelines in a convenient, electronic form. Requires the Agency to enter into an agreement with the NLM to implement this paragraph. Requires that the Agency's Administrator carry out provisions relating to the Forum for Quality and Effectiveness in Health Care through the Form's Director. Provides for the selection and composition of panels convened by the Director. Limits the percentage of members of grant and contract peer review groups who may be U.S. officers or employees. (Currently, U.S. officers and employees are excluded from the groups.) Revises other requirements regarding the groups. Allows the Agency to tabulate and analyze statistics and prepare studies for public or nonprofit private entities who pay the costs of such services. Modifies requirements for the agenda for development of guidelines, standards, performance measures, and review criteria, including covering at least three conditions that account for significant national health expenditures. Mandates production of an annual list of priority guideline topics. Modifies, with regard to guidelines, standards, performance measures, and review criteria, requirements concerning: (1) pilot testing; and (2) evaluations. Mandates studies of: (1) cost estimating methods for alternative treatments included in guidelines; and (2) the processes by which guidelines and standards are developed and disseminated. Requires the National Advisory Council for Health Care Policy, Research, and Evaluation to advise the Agency's Administrator on the selection of Guideline Panels and the Chairpersons of the Panels and to participate in the production of the annual list of priority guideline topics. Removes provisions establishing a subcouncil of the Council to carry out specified duties. Authorizes appropriations to carry out provisions relating to the Agency. Authorizes appropriations for demonstration projects on emergency medical services for children.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

4 official files

Reported to Senate (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.